The U.S. Department of Health and Human Services (HHS), working with the Drug Enforcement Administration (DEA), has issued a fourth temporary extension of telemedicine flexibilities, first introduced in response to the...more
1/21/2026
/ DEA ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Government Agencies ,
Healthcare ,
New Regulations ,
Patient Access ,
Pharmaceutical Industry ,
Prescription Drugs ,
Proposed Rules ,
Regulatory Requirements ,
Telehealth ,
Telemedicine